In this study, we attempt to clarify the expression and regulation of lncRNA MEG3, TNF-α, and lipogenesis genes in HepG2 cells and explore possible intervention mechanism, providing new evidence for the prevention and treatment of NAFLD. Here, MEG3 is linked to metabolic dysfunction-associated steatotic liver disease.